Week 2 Flashcards

1
Q

3 types of cancer treatment

A

radiation
surgery
chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

examples of precision medicine

A

targeted therapy

immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neoadjuvant (preoperatively) are used for what

A

administered prior to surgery to facilitate resection and prevent metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adjuvant (postoperatively) are used for

A

after surgical debulking to kill micrometastases and reduce risk of distant relapse; increase disease-free survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

examples of alkylating agents

A

Cisplatin, Carboplatin, Oxaliplatin, Busulfan, Chlorambucil, Dacarbarzine,
Mechlorethamine (Nitrogen Mustard), Mephalan, Nitroureas, Procarbazine, Temozolamid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

examples of antimetabolites

A

Methotrexate, Fluorouracil, Mercaptopurine, Thioguanine, Cytarabin, Hydroxyurea,
Fludarabine, Leucovorin, Capecitabine, Gemcitabine, Aracytidine, Pemetrexed, Trimexrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

examples of mitotic spindle agents

A

Docetaxel, Paclitaxel [Taxol], Vincristine, Vinblastine, Cabazitaxel, Eribulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

topoisomerase inhibitors examples

A

Topo I inhibitors – Irinotecan, Topotecan; Topo II inhibitors – Etoposide, Teniposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do Antimetabolites do

A

limit the synthesis of nucleic acid precursors e.g. methotrexate inhibits dihydrofolate reductase, reducing the synthesis of folate which is necessary for purine and pyrimidine production. Similar agents – 5-fluorouracil, cytarabine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do Topoisomerase enzymes do

A

participate in the winding and unwinding of DNA and are inhibited by anthracyclines (doxorubicin, daunorubicin, epirubicin), epipodophyllotoxins (etoposide, teniposide) and camptothecins (irinotecan, topotecan).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PARAMETERS TO BE EVALUATED IN SYSTEMIC TREATMENTS response

A
Complete response (CR): disappearance of all target lesions.
Partial response (PR): at least a 30% decrease in the sum of the longest diameter (LD) of targeted lesions.
Stable disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD.
Progressive disease (PD): at least a 20% increase in the sum of the LD of targeted lesions.
Duration of response or time to progression (TTP): the time from response to progression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PARAMETERS TO BE EVALUATED IN SYSTEMIC TREATMENTS SURVIVAL

A
Disease-free survival (DFS): from the time of treatment to first recurrence.
Overall survival (OS): from the time of diagnosis to death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is mucositis and its symptoms and treatment

A

common complication of cancer chemotherapy
oral pain and burning
ulcerations
analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is P-glycoprotein (PGP) encoded by the MDR1 gene

A

multidrug resistance gene.
P-glycoprotein (PGP) mediates transport of certain drugs out of the cell thereby reducing their intracellular concentration and cytotoxicity.
PGP over-expression achieved increased expression of its mRNA with or without MDR1 gene amplification.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how can resistance be tackled

A

increasing the levels of platinum reaching tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

tumour margin meaning

A

removing the rim of normal tissue surrounding the tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drug resistance is effected by microenvironments give examples of what

A

fibroblasts
exosomes
vascualar abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how is dna damaged included by ionizing radiation

A

doubled stranded base pair is damaged to stop replication leading to cell death
base and sugar damage, single-strand breaks,
double-strand breaks, and covalent intrastrand or interstrand crosslinking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the process of DNA

A

DNA damage is recognised by DNA damage sensor proteins,
(ii) transducer proteins then signal to effectors and (iii) this results in either cell cycle arrest, DNA repair or apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what factors affect the response of tumour to radiation

A

cell intrinsic
microenvironment
right ph and oxygen in the tumour

21
Q

types of radiotherapy

A
Radical radiotherapy 
Adjuvant radiotherapy 
Palliative radiotherapy 
EXTERNAL BEAM RADIOTHERAPY
BRACHYTHERAPY
RADIOISOTOPE THERAPY
PROTON THERAPY
22
Q

Radical radiotherapy

A

intent to cure either as primary therapy (e.g. early stage Hodgkin’s lymphoma) or as an alternative to surgery
preserves normal anatomy

23
Q

Adjuvant radiotherapy and an example

A

administered as an adjunct to potentially curative surgery.
breast cancer

24
Q

Palliative radiotherapy what is it

A

control of distressing symptoms. Not curative. Improve quality of life. Relieve pain due to bone metastases and nerve compression. Reduce haemorrhage and obstructions. Brain metastases.

25
Q

EXTERNAL BEAM RADIOTHERAPY

A

X-rays, gamma rays and electron beams from linear accelerators. High intensity electron beam (4-20MeV) has greater penetration, less scatter, delivers high energy to deep-seated tumours while sparing normal tissues in its pathway.

26
Q

BRACHYTHERAPY

A

Use of radioactive sources implanted directly into a tumour or body cavity to deliver localised radiotherapy

27
Q

RADIOISOTOPE THERAPY

what are examples

A

Internal isotope treatment given either orally or systemically by injection.
Can only be used where a tumour is in a tissue that will preferentially accumulate a specific isotope.
Radioiodine (I-131) for the treatment of thyroid cancer.

28
Q

PROTON THERAPY

and its examples

A

Form of radiotherapy that uses protons instead of x-rays.
High energy proton beams target tumours more precisely.
Generated using a synchrotron or cyclotron.
Less radiation dose outside the tumour – less damage to healthy tissues.
Causes fewer short and long-term side effects.
Proven to be effective in adults and children – brain cancer.

29
Q

how does radiation induced immune response in cancer therapy work

A

Radiation induces the release of tumour antigens
captured and processed by antigen-presenting cells (APCs) to activate
cytotoxic T lymphocytes (CTL).
CTL are recruited to attack primary tumour or metastatic tumour cells (abscopal effect).
Radiation up-regulates PD-L1 and in combination with anti-PD-L1 therapy (immune checkpoint inhibitor therapy)
enhances MHC and Fas expression on tumour cells
increases CTL-mediated cytotoxicity
including the release of cytokines to further
enhance killing of primary and metastatic tumour cells.

30
Q

what are the types of immunotherapy

A

Therapeutic vaccines – modified tumour cells, tumour-associated antigens, dendritic cells, oncolytic viruses.
Immune system modulators – cytokines (e.g. IL-2), interferons.
Monoclonal antibodies – targets on tumour cells (e.g. CD20 on B cell lymphomas).
Adoptive T cell transfer – tumour-infiltrating T cells, peripheral T cells, CAR T cells.
Immune checkpoint inhibitors – taking the breaks off the immune system.

31
Q

how is tumour associated antigens classified

A

4 ways

32
Q

cancer germline what is it

A

Expressed only by tumour cells and adult reprodutive tissues

33
Q

Differentiation

A

Expressed by tumours and limited range of normal issues

34
Q

Over expressed

A

It is expressed by both normal and tumour cells but more in tumour cell s

35
Q

How does Dendritic cell vaccines work

A
eluriated moncytes are cultured 
with IL-4 and GM-CSF
immature DCs are produced 
matured with CD40
pulsed with a peptide with an expression vector 
injected in a patient 
as a autologous vaccine 
induces T cell immune response
36
Q

Dendritic cells

A

cells are modified outside of the body after taking them from the patient then put back in as a form of therapy

37
Q

precautions and flaws

A

too much cytokines can interfere in the microenvironment and can cause the tumour to grow more

38
Q

what is pegalating to overcome half life

A

polyethalinegylcol with cytokine as single agents are better combined in other therapies

39
Q

Adoptive T cell therapy

A
make t cells better killers
by in vitro stimulation 
tumour taken 
isolate them 
tils 
grown outside 
and then infused back into the patient
conditioning their body by imunosupress them the t cells then expand in the body
40
Q

IL2 does what

A

stimulates growth

41
Q

how doe CAR T cell therapy work

A
blood in taken from the patient 
Then the CAR gene is inserted into the  T cells to produce CAR t cells
millions are made in the lab
in order to put them back into the body
so they can bind to cancer cells
to kill cancer cells alone
42
Q

Schemetic of a T cell

A
Using T cell receptor as antibody
targets with a tumour 
the modifies antibody 
binds on the tail 
activate the t cell to be cytotoxic
then kills the cancer cells
43
Q

immune checkpoint inhibition

A

activation signal
inhibirity signal given to stop over stimulation
stimulation of T cell
CTLA 4 and PD1 important to put breaks on T cells to stop over stimualtion

44
Q

PD1 can do what

A

It can switch off T cells.

45
Q

Monoclonal antibodies can do what

A

block PD1 and stops the production of CTLA4

46
Q

problems with immune checkpoint inhibtion

A

over activatio. can over saturate the micro envrionment making it hard for t cells to kill cancer cells

47
Q

what does imatinib do and mec

A

competes with the atp for the able kinase
stops the bality of the kinsase to work
affects the progression of CML

48
Q

BCR2 controls what

A

apoptosis